Innovent Biologics Inc

Overview

Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company's product portfolio includes monoclonal antibodies and agonistic antibodies. Its products are used for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, and other autoimmune diseases. Innovent Biologics development platform provides pilot process development and preclinical and clinical research stage that shortens the development cycle of new drugs. The company operates in fields of oncology, autoimmune disease and ophthalmology with application to different indications. It markets its products across China. Innovent Biologics is headquartered in Suzhou, China.
Key Stats
Address
Dongping Street, Suzhou Industrial Park, Suzhou, Jiangsu
Headquarters

China

No of Employees

4,596

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

1801 [HKG]

Revenue (2020)

$557 m

267.3% (2020 vs 2019)
Net Income (2020)

$-145 m

41.8% (2020 vs 2019)
Net Profit Margin

-26 %

84.2% (2020 vs 2019)
Market Cap *

$13,620 m

EPS *

$-0.7

  *Note: Ratios based on the share price as of 6-October-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Innovent Biologics IncWuXi Biologics Cayman IncHainan Haiyao Co Ltd
Key Information
Headquarters China China China
Headquarter City Suzhou Wuxi Haikou
Headquarter State/Province Jiangsu Jiangsu Hainan
No. of Employees 4,596 7,686 3,148
Entity Type Public Public Public

Products & Services

Innovent Biologics is a biopharmaceutical company. Key products offered by the company include the following:

Products
  • Pipeline
  • Monoclonal Antibody:
  • IBI301
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Brands
  • TYVYT
  • BYVASDA
  • SULINNO
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In September, the company entered into a collaboration and license agreement with UNION Therapeutics for…
2021 Contracts/Agreements In August, the company announced a drug research and development collaboration with Bolt Biotherapeutics to…
2021 Regulatory Approval In June, the company and Eli Lilly and Company jointly secured a NMPA approval from…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Innovent Biologics (Shanghai) Co Ltd

Address

T1-11 Floor, SOHO Tianshan Plaza, 421 Ziyun Road, Shanghai
China

Telephone

86 021 31837200

Innovent Biologics (Suzhou) Co Ltd

Address

Suzhou Industrial Park, 168 Dongping Street
China

Telephone

86 512 69566088

Website

www.innoventbio.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
19 Jan 2021 PT Etana Biotechnologies to Enter into Licensing Agreement with Innovent Biologics Licensing Agreement PT Etana Biotechnologies Innovent Biologics Inc
18 Feb 2019 Chipscreen Biosciences Enters into Agreement with Innovent Biologics Partnership Innovent Biologics Inc; Shenzhen Chipscreen Biosciences Co Ltd
16 Dec 2018 Innovent Biologics Enters into Licensing Agreement with Incyte Licensing Agreement Innovent Biologics Inc Incyte Corp
29 Nov 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
18 Oct 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
26 Apr 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

67

Active Jobs

0

Posted

3

Closed

Job Trends

Latest Jobs

Job title Company Country
Class of 2022-Packaging Technician/Assistant Engineer (J12334) Innovent Biologics Inc China
Class of 2022-Preparation Technician/Assistant Engineer (J12333) Innovent Biologics Inc China
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar